Stephen Huhn
Hoofd Techniek/Wetenschap/O&O bij CONTINEUM THERAPEUTICS, INC.
Vermogen: - $ op 30-04-2024
Profiel
Stephen L.
Huhn is currently the Chief Medical Officer & SVP-Clinical Development at Contineum Therapeutics, Inc. He previously worked as the Chief Medical Officer & VP-CNS Clinical Research at StemCells, Inc. from 2014 to 2015.
Prior to that, he held the position of Associate Professor-Neurosurgery at Stanford University.
Dr. Huhn obtained his doctorate degree from the University of Arizona in 1987.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 04-04-2024 | 0 ( -.--% ) | - $ | 30-04-2024 |
Actieve functies van Stephen Huhn
| Bedrijven | Functie | Begin |
|---|---|---|
| CONTINEUM THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2020 |
Eerdere bekende functies van Stephen Huhn
| Bedrijven | Functie | Einde |
|---|---|---|
StemCells, Inc.
 StemCells, Inc. BiotechnologyHealth Technology StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA. | Hoofd Techniek/Wetenschap/O&O | - |
| Stanford University | Corporate Officer/Principal | - |
Opleiding van Stephen Huhn
| University of Arizona | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CONTINEUM THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
StemCells, Inc.
StemCells, Inc. BiotechnologyHealth Technology StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA. | Health Technology |
